首页> 外文期刊>BioMed research international >Sulfa Drugs as Inhibitors of Carbonic Anhydrase: New Targets for the Old Drugs
【24h】

Sulfa Drugs as Inhibitors of Carbonic Anhydrase: New Targets for the Old Drugs

机译:Sulfa药物作为碳酸酐酶的抑制剂:旧药物的新靶标

获取原文
获取原文并翻译 | 示例
           

摘要

Sulfa drugs are well-known antibacterial agents containing N-substituted sulfonamide group on para position of aniline ring (NH2RSO2NHR'). In this study 2,4-dichloro-l,3,5-triazine derivatives of sulfa drugs, sulfamerazine (lb), sulfaquinoxaline (2b), sulfadiazine (3b), sulfadimidine (4b), and sulfachloropyrazine (5b) (la-5a) were synthesized and characterized. Their carbonic anhydrase inhibition activity was evaluated against bovine cytosolic carbonic anhydrase isozyme II (bCA II). For the sake of comparison the CA inhibition activity of the parent sulfa drugs (lb-5b) was also evaluated. A significant increase in CA inhibition activity of sulfa drugs was observed upon substitution with 2,4-dichloro-l,3,5-triazine moiety. Molecular docking studies were carried out to highlight binding site interactions. ADME properties were calculated to evaluate drug likeness of the compounds.
机译:Sulfa药物是含有N-取代的磺酰胺基团的公知的抗菌剂,苯胺环(NH 2 RSO2NHR')的para位置上。 在本研究中,磺胺类药物的2,4-二氯-1,3,5-三嗪衍生物,磺胺嘧啶(LB),磺胺喹啉(2b),磺胺嗪(3b),磺酰丙氨酸(4b)和磺氯酰吡嗪(5b)(la-5a )被合成并表征。 对牛酸酐酶抑制活性评估对牛胞质碳酸酐酶同工酶II(BCA II)评价。 为了比较,还评估了亲本磺生物(LB-5B)的Ca抑制活性。 在用2,4-二氯-1,3,5-三嗪部分取代时,观察到磺胺类药物的Ca抑制活性显着增加。 进行分子对接研究以突出结合位点相互作用。 计算Adme属性以评估化合物的药物象征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号